Stocksigma LogoStocksigma Logo

Unichem Laboratories Reports Q2 FY27 Results: Consolidated PAT Reaches ₹22.22 Crore

Unichem Laboratories reported consolidated revenue from operations of ₹640.22 crore for Q2 ended 30th Sep'26, up 10.58% YoY from ₹578.96 crore and up 1.20%

Unichem Laboratories Reports Q2 FY27 Results: Consolidated PAT Reaches ₹22.22 Crore

Unichem Laboratories Ltd · Financial Result · 04 Nov 2026, 7:31 pm

Unichem Laboratories Reports Q2 FY27 Results: Consolidated PAT Reaches ₹22.22 Crore Unichem Laboratories reported consolidated revenue from operations of ₹640.22 crore for Q2 ended 30th Sep'26, up 10.58% YoY from ₹578.96 crore and up 1.20% QoQ. Consolidated profit before exceptional items stood at ₹51.63 crore versus ₹47.44 crore in Q2 FY26. Following an exceptional claim provision of ₹24.26 crore related to UK Perindopril litigation by subsidiary Niche Generics, net profit after tax reached ₹22.22 crore, rebounding from a loss of ₹11.89 crore YoY. Standalone revenue grew 12.61% YoY to ₹401.90 crore with PAT of ₹1.49 crore.

Original exchange filing (PDF)

More announcements from Unichem Laboratories Ltd

All Unichem Laboratories Ltd announcements